Our Research

Research Strategy


The Institute of Ageing and Chronic Disease recentuly underwent a review of its research activity, assessing the eficacy, focus and translational benefit to society. After a period of consultation and discussion, a new strategy was established.

We believe the new research strategy encapsulates the importance of our research both to fundamental scientific discover and ultimately to the impact agenda within ageing and chronic disease. It demonstrates the range of high quality research that is ongoing within the Institute and how we can work together to reach beyond our current position and move towards the translation of our research to influence the health and wellbeing of society.

The new strategy aims to categorise ongoing and future research into 3 themes:


  • Materials and Technology
  • Therapeutics and Interventions
  • Behaviour and Prevention


You can download the full research strategy below

IACD Research Strategy 2018


How do we acheive this?


Our staff have a diverse range of backgrounds and disciplines, including medicine, veterinary sciences, biomaterials, engineering, computer modelling, molecular biology and physiology.

It is the fact that we work with both humans and animals, sharing the expertise gained by studying different species, which makes the Institute unique. Not only do we aim to help individuals lead more active, healthier lives, we are able to respond effectively to the needs of an ageing population.

In many of our specialisms, we take a ‘bench-to-bedside’ approach, but we also reverse this process, taking real issues from clinical practice into the laboratory to find revolutionary solutions.

We adopt innovative research methods – under the microscope as well as in dynamic facilities like our gait laboratory – to study whole body systems and the impact of outside factors. We don’t look at anything in isolation – be that individual cells or the entire musculoskeletal system.


Our research areas:



Our national partners include the Universities of Sheffield and Newcastle, whilst international collaborators include the Universities of Michigan and San Antonio in the USA.

Thanks to the new cutting-edge facilities in the University of Liverpool’s William Henry Duncan Building we have an innovative workspace for clinical and non-clinical scientists to carry out their research into diseases, as well as the mechanisms behind them.